Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-007100-42Phase 3Completed
Phase 3 trial of prednisolone in wheeze, asthma and rhinoviral infection, sponsored by Turku University Hospital. Primary endpoints: Time to new wheezing episode within 2 months, Number of wheezing episodes within 12 months and 1 more. Started Jan 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-007100-42.